Literature DB >> 76845

Brain-aluminium concentration in dialysis encephalopathy.

J R McDermott, A I Smith, M K Ward, I S Parkinson, D N Kerr.   

Abstract

Brain-aluminium concentrations were found to be significantly higher in 7 patients dying with dialysis encephalopathy (mean 15.9 microgram aluminium/g dry weight) than in 11 dialysed controls (4.4 microgram/g) and in 2 uraemic patients who were not dialysed (2.7 microgram/g). The grey matter from the patients with dialysis encephalopathy contained about three times as much aluminium as white matter. The results suggest that dialysis with untreated and/or softened tap-water (aluminium concentration 0.1-1.2 mg/1) makes the major contribution to brain-aluminium levels; dialysis with deionised water (aluminium concentration normally less than 0.02 mg/1) and intake of phosphate-binding AL(OH)3 gel are less important. Brain aluminium levels remain elevated for up to four years after restoration of good renal function by transplantation. The association of dialysis encephalopathy with high levels of aluminium in the brain and in the dialysis water emphasises the potential neurotoxicity of aluminium in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76845     DOI: 10.1016/s0140-6736(78)90681-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Some medical applications of the oxford scanning proton microprobe.

Authors:  D J Vaux; G W Grime; F Watt
Journal:  Biol Trace Elem Res       Date:  1987-08       Impact factor: 3.738

3.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.

Authors:  H A Ellis; J H McCarthy; J Herrington
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

5.  Compartment syndromes in unconscious patients: a simple aid to diagnosis.

Authors:  A C Macey
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

6.  Multiorgan aluminium deposits in a chronic haemodialysis patient. Electron microscope and microprobe studies.

Authors:  A Roth; C Nogues; P Galle; T Drüeke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 7.  A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders.

Authors:  Virginie Rondeau
Journal:  Rev Environ Health       Date:  2002 Apr-Jun       Impact factor: 3.458

8.  Aluminium intoxication in undialysed adults with chronic renal failure.

Authors:  L S Russo; G Beale; S Sandroni; W E Ballinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

9.  Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis.

Authors:  E Reusche; U Seydel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

Authors:  D R Crapper; S Quittkat; S S Krishnan; A J Dalton; U De Boni
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.